Cargando…

Nicotinamide Prevents Diabetic Brain Inflammation via NAD+-Dependent Deacetylation Mechanisms

This study investigated the effect of nicotinamide (NAM) supplementation on the development of brain inflammation and microglial activation in a mouse model of type 1 diabetes mellitus. C57BL/6J male mice, which were made diabetic with five consecutive, low-dose (55 mg/kg i.p.) streptozotocin (STZ)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Torres-Méndez, Jeimy Katherine, Niño-Narvión, Julia, Martinez-Santos, Patricia, Diarte-Añazco, Elena María Goretti, Méndez-Lara, Karen Alejandra, del Olmo, Tania Vázquez, Rotllan, Noemi, Julián, Maria Teresa, Alonso, Núria, Mauricio, Didac, Camacho, Mercedes, Muñoz, Juan Pablo, Rossell, Joana, Julve, Josep
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383777/ https://www.ncbi.nlm.nih.gov/pubmed/37513501 http://dx.doi.org/10.3390/nu15143083

Ejemplares similares

Therapeutic Potential of Emerging NAD+-Increasing Strategies for Cardiovascular Diseases
por: Rotllan, Noemi, et al.
Publicado: (2021)

NAD+ Precursors: A Physiological Reboot?
por: Niño-Narvión, Julia, et al.
Publicado: (2023)

NAD+ Precursors and Intestinal Inflammation: Therapeutic Insights Involving Gut Microbiota
por: Niño-Narvión, Julia, et al.
Publicado: (2023)

NAD+-Increasing Strategies to Improve Cardiometabolic Health?
por: Blanco-Vaca, Francisco, et al.
Publicado: (2022)

Nicotinamide Prevents Apolipoprotein B-Containing Lipoprotein Oxidation, Inflammation and Atherosclerosis in Apolipoprotein E-Deficient Mice
por: Méndez-Lara, Karen Alejandra, et al.
Publicado: (2020)

Novel Insights into the Role of HDL-Associated Sphingosine-1-Phosphate in Cardiometabolic Diseases
por: Diarte-Añazco, Elena M. G., et al.
Publicado: (2019)

FTY720-P, a Biased S1PR Ligand, Increases Mitochondrial Function through STAT3 Activation in Cardiac Cells
por: Muñoz, Juan Pablo, et al.
Publicado: (2023)

The Bittersweet Beat: Diabetes Complications
por: Rossell, Joana, et al.
Publicado: (2023)

NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health
por: Alegre, Gabriela Fabiana Soares, et al.
Publicado: (2023)

The NAD(+) precursor nicotinamide riboside decreases exercise performance in rats
por: Kourtzidis, Ioannis A., et al.
Publicado: (2016)

Epigenetic Regulation by microRNAs in Hyperhomocysteinemia-Accelerated Atherosclerosis
por: Griñán, Raquel, et al.
Publicado: (2022)

The emergence of the nicotinamide riboside kinases in the regulation of NAD(+) metabolism
por: Fletcher, Rachel S, et al.
Publicado: (2018)

The Effect of Nicotinamide Riboside, an NAD + Precursor, on Glycolysis and NAD + Salvage Pathway in Alcohol-Stimulated Macrophages
por: Kang, Hyunju, et al.
Publicado: (2022)

Metabolism and biochemical properties of nicotinamide adenine dinucleotide (NAD) analogs, nicotinamide guanine dinucleotide (NGD) and nicotinamide hypoxanthine dinucleotide (NHD)
por: Yaku, Keisuke, et al.
Publicado: (2019)

Nicotinamide Riboside Kinase Structures Reveal New Pathways to NAD(+)
por: Tempel, Wolfram, et al.
Publicado: (2007)

Balancing NAD(+) deficits with nicotinamide riboside: therapeutic possibilities and limitations
por: Cercillieux, Angelique, et al.
Publicado: (2022)

Predictive Value of the Advanced Lipoprotein Profile and Glycated Proteins on Diabetic Retinopathy
por: Julve, Josep, et al.
Publicado: (2022)

Impaired nicotinamide adenine dinucleotide (NAD(+)) metabolism in diabetes and diabetic tissues: Implications for nicotinamide‐related compound treatment
por: Fan, Lan, et al.
Publicado: (2020)

A reduced form of nicotinamide riboside defines a new path for NAD(+) biosynthesis and acts as an orally bioavailable NAD(+) precursor
por: Giroud-Gerbetant, Judith, et al.
Publicado: (2019)

The significance of NAD + metabolites and nicotinamide N-methyltransferase in chronic kidney disease
por: Takahashi, Rina, et al.
Publicado: (2022)

Enzymatic and Chemical Syntheses of Vacor Analogs of Nicotinamide Riboside, NMN and NAD
por: Sverkeli, Lars Jansen, et al.
Publicado: (2021)

Nicotinamide Adenine Dinucleotide (NAD) Metabolism as a Relevant Target in Cancer
por: Navas, Lola E., et al.
Publicado: (2022)

Nicotinamide Phosphoribosyltransferase (Nampt)/Nicotinamide Adenine Dinucleotide (NAD) Axis Suppresses Atrial Fibrillation by Modulating the Calcium Handling Pathway
por: Feng, Duo, et al.
Publicado: (2020)

An NAD(+)-Dependent Deacetylase SIRT7 Promotes HCC Development Through Deacetylation of USP39
por: Dong, Ling, et al.
Publicado: (2020)

Nicotinamide Mononucleotide, an Intermediate of NAD(+) Synthesis, Protects the Heart from Ischemia and Reperfusion
por: Yamamoto, Takanobu, et al.
Publicado: (2014)

Potential of nicotinamide adenine dinucleotide (NAD) for management of root-knot nematode in tomato
por: Regmi, Homan, et al.
Publicado: (2021)

Nicotinamide restores tissue NAD(+) and improves survival in rodent models of cardiac arrest
por: Zhu, Xiangdong, et al.
Publicado: (2023)

Nicotinamide Riboside and Dihydronicotinic Acid Riboside Synergistically Increase Intracellular NAD(+) by Generating Dihydronicotinamide Riboside
por: Ciarlo, Eleonora, et al.
Publicado: (2022)

Fatty Acid Binding Proteins 3 and 4 Predict Both All-Cause and Cardiovascular Mortality in Subjects with Chronic Heart Failure and Type 2 Diabetes Mellitus
por: Rodríguez-Calvo, Ricardo, et al.
Publicado: (2023)

Nicotinamide Mononucleotide: A Promising Molecule for Therapy of Diverse Diseases by Targeting NAD+ Metabolism
por: Hong, Weiqi, et al.
Publicado: (2020)

NAD(+) augmentation with nicotinamide riboside improves lymphoid potential of Atm(−/−) and old mice HSCs
por: Zong, Le, et al.
Publicado: (2021)

The key role of the NAD biosynthetic enzyme nicotinamide mononucleotide adenylyltransferase in regulating cell functions
por: Fortunato, Carlo, et al.
Publicado: (2021)

Association of α-klotho with subclinical carotid atherosclerosis in subjects with type 1 diabetes mellitus
por: Castelblanco, Esmeralda, et al.
Publicado: (2022)

NAD(+)-SIRT1 control of H3K4 trimethylation through circadian deacetylation of MLL1
por: Aguilar-Arnal, Lorena, et al.
Publicado: (2015)

Contribution of Elevated Glucose and Oxidized LDL to Macrophage Inflammation: A Role for PRAS40/Akt-Dependent Shedding of Soluble CD14
por: Sanjurjo, Lucía, et al.
Publicado: (2023)

A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degeneration
por: Di Stefano, M, et al.
Publicado: (2015)

Mimic of the Cellular Antioxidant Defense System for a Sustainable Regeneration of Nicotinamide Adenine Dinucleotide (NAD)
por: Jo, Seong-Min, et al.
Publicado: (2020)

Nicotinamide mononucleotide adenylyltransferase uses its NAD(+) substrate-binding site to chaperone phosphorylated Tau
por: Ma, Xiaojuan, et al.
Publicado: (2020)

Induction of the nicotinamide riboside kinase NAD(+) salvage pathway in a model of sarcoplasmic reticulum dysfunction
por: Doig, Craig L., et al.
Publicado: (2020)

Nicotinamide Phosphoribosyltransferase‐elevated NAD(+) biosynthesis prevents muscle disuse atrophy by reversing mitochondrial dysfunction
por: Zhang, Yao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mvr5vq5p3gklsrnnc9p4m15h2q